JENTADUETO XR FDA approval date

The FDA approved JENTADUETO XR on 27 May 2016.

FDA approval date
27 May 2016

Drug identity has not yet been verified against registry records

Also recorded as LINAGLIPTIN; METFORMIN HYDROCHLORIDE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2016-05-27DayJENTADUETO XRFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA208026", "applicant_as_listed_by_fda": "BOEHRINGER INGELHEIM", "brand_names": ["JENTADUETO XR"], "active_ingredients": ["LINAGLIPTIN", "METFORMIN HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20160527", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026